Idiopathic intracranial hypertension and hemophilia A

被引:9
|
作者
Jacome, DE
机构
[1] Franklin Med Ctr, Dept Med, Greenfield, IN USA
[2] Dartmouth Hitchcock Med Ctr, Div Neurol, Lebanon, NH 03766 USA
来源
HEADACHE | 2001年 / 41卷 / 06期
关键词
idiopathic intracranial hypertension; hemophilia A; lumbar puncture; iron deficiency anemia; headache;
D O I
10.1046/j.1526-4610.2001.041006595.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-A patient with hemophilia A and long-standing recurrent symptoms of idiopathic intracranial hypertension is described. During his relapses, he experienced headache, and attention and language disturbance, but no visual symptoms. Background.-Hemophilia A is a rare inherited coagulation disorder secondary to factor VIII deficiency. Idiopathic intracranial hypertension has been reported in association with prothrombotic conditions and iron deficiency anemia, but not in patients with hemophilia A. Recurrent or chronic headache is not a typical symptom of hemophilia, but headache is a presenting sign of intracranial bleed in persons with hemophilia, Methods.-Medical history review, clinical neurologic examination, brain magnetic resonance imaging, computed head tomography, and electroencephalogram were performed. Results.-Neurologic examination revealed bilateral papilledema during relapses of idiopathic intracranial hypertension. Multiple lumbar punctures preceded by the intravenous administration of factor VIII early in the course of the illness confirmed the presence of elevated cerebrospinal fluid pressures and absence of subarachnoid blood. He had no complications from lumbar punctures. Initial electroencephalograms showed background slowing but later normalized. Magnetic resonance imaging of the brain and computerized tomography of the head were normal. Relapses of idiopathic intracranial hypertension were eventually controlled with the administration of acetazolamide, Conclusion.-Idiopathic intracranial hypertension may develop in patients with hemophilia A in the absence of visual symptoms. Therapeutic and diagnostic lumbar punctures were safe to perform on this patient, following the administration of factor VIII.
引用
收藏
页码:595 / 598
页数:4
相关论文
共 50 条
  • [1] Idiopathic intracranial hypertension
    Boyter, Elizabeth
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (05): : 30 - 35
  • [2] Idiopathic intracranial hypertension
    Wakerley, B. R.
    Tan, M. H.
    Ting, E. Y.
    CEPHALALGIA, 2015, 35 (03) : 248 - 261
  • [3] Idiopathic intracranial hypertension
    Binder, DK
    Horton, JC
    Lawton, MT
    McDermott, MW
    NEUROSURGERY, 2004, 54 (03) : 538 - 551
  • [4] Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial
    Friedman, Deborah I.
    Quiros, Peter A.
    Subramanian, Prem S.
    Mejico, Luis J.
    Gao, Shan
    McDermott, Michael
    Wall, Michael
    HEADACHE, 2017, 57 (08): : 1195 - 1205
  • [5] Idiopathic intracranial hypertension pathogenesis: The jugular hypothesis
    Fargen, Kyle M.
    Midtlien, Jackson P.
    Margraf, Connor R.
    Hui, Ferdinand K.
    INTERVENTIONAL NEURORADIOLOGY, 2024,
  • [6] Idiopathic Intracranial Hypertension and Multiple Sclerosis Overlap
    Stoutin, Jaqueline
    Fan, Jerry
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [7] Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
    Virdee, Jasvir
    Larcombe, Stephanie
    Vijay, Vivek
    Sinclair, Alex J.
    Dayan, Margaret
    Mollan, Susan P.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 767 - 781
  • [8] Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
    Jasvir Virdee
    Stephanie Larcombe
    Vivek Vijay
    Alex J. Sinclair
    Margaret Dayan
    Susan P. Mollan
    Ophthalmology and Therapy, 2020, 9 : 767 - 781
  • [9] Update on Idiopathic Intracranial Hypertension
    Wall, Michael
    NEUROLOGIC CLINICS, 2017, 35 (01) : 45 - +
  • [10] Update on Idiopathic Intracranial Hypertension
    Kanagalingam, Sivashakthi
    Subramanian, Prem S.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (07)